title: Antinociceptive effect of the C-terminus of murine S100A9 protein on experimental neuropathic pain.
abstract: The synthetic peptide identical to the C-terminus of murine S100A9 protein (mS100A9p) has antinociceptive effect on different acute inflammatory pain models. In this study, the effect of mS100A9p was investigated on neuropathic pain induced by chronic constriction injury (CCI) of the sciatic nerve in rats. Hyperalgesia, allodynia, and spontaneous pain were assessed to evaluate nociception. These three signs were detected as early as 2 days after sciatic nerve constriction and lasted for over 14 days after CCI. Rats were treated with different doses of mS100A9p by intraplantar, oral, or intrathecal routes on day 14 after CCI, and nociception was evaluated 1h later. These three routes of administration blocked hyperalgesia, allodynia and spontaneous pain. The duration of the effect of mS100A9p depends on the route used and phenomenon analyzed. Moreover, intraplantar injection of mS100A9p in the contralateral paw inhibited the hyperalgesia on day 14 days after CCI. The results obtained herein demonstrate the antinociceptive effect of the C-terminus of murine S100A9 protein on experimental neuropathic pain, suggesting a potential therapeutic use for it in persistent pain syndromes, assuming that tolerance does not develop to mS100A9p.
authors.affiliation: Laboratory of Pathophysiology, Butantan Institute, Sao Paulo, SP, Brazil.
authors.forename: Carina Cicconi
authors.initials: CC
authors.lastname: Paccola
authors.forename: Vanessa Pacciari
authors.initials: VP
authors.lastname: Gutierrez
authors.forename: Ingrid
authors.initials: I
authors.lastname: Longo
authors.forename: Luiz
authors.initials: L
authors.lastname: Juliano
authors.forename: Maria Aparecida
authors.initials: MA
authors.lastname: Juliano
authors.forename: Renata
authors.initials: R
authors.lastname: Giorgi
mesh_terms: D000700:Analgesics / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D040502:Calgranulin B / Q000008:administration & dosage / Q000627:therapeutic use*; D006930:Hyperalgesia; D008297:Male; D051379:Mice; D010146:Pain / Q000188:drug therapy*; D010147:Pain Measurement; D010455:Peptides / Q000008:administration & dosage / Q000627:therapeutic use*; D051381:Rats; D017208:Rats, Wistar; D012584:Sciatic Nerve / Q000293:injuries
chemical_list: D000700:Analgesics; D040502:Calgranulin B; D010455:Peptides